Results 21 to 30 of about 1,671,061 (305)

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities

open access: yesFrontiers in Oncology, 2022
Hepatocellular carcinoma is one of the leading causes of cancer mortality globally, and its incidence is increasing. Immune checkpoint therapy has revolutionized the treatment of hepatocellular carcinoma over the past few years.
Qingqing Xie   +4 more
doaj   +1 more source

Immune Checkpoints in Viral Infections [PDF]

open access: yesViruses, 2020
As evidence has mounted that virus-infected cells, such as cancer cells, negatively regulate the function of T-cells via immune checkpoints, it has become increasingly clear that viral infections similarly exploit immune checkpoints as an immune system escape mechanism.
Huiming Cai   +11 more
openaire   +3 more sources

Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy

open access: yesNanomaterials, 2021
Immune checkpoint receptor signaling pathways constitute a prominent class of “immune synapse,” a cell-to-cell connection that represses T-lymphocyte effector functions.
Chiara Cremolini   +3 more
doaj   +1 more source

Myocarditis with Immune Checkpoint Blockade [PDF]

open access: yesNew England Journal of Medicine, 2017
In their discussion of fulminant myocarditis and complete heart block during immune checkpoint therapy, Johnson et al. do not discuss the possible role of circulating anticonductive tissue autoantibodies (ACTA) in the pathogenesis of the sudden heart block and myocarditis.1 Since it is not known which autoantigens (other than troponin I, which was ...
Javid J, Moslehi   +2 more
openaire   +5 more sources

DNA replication is required for the checkpoint response to damaged DNA in Xenopus egg extracts. [PDF]

open access: yes, 2002
Alkylating agents, such as methyl methanesulfonate (MMS), damage DNA and activate the DNA damage checkpoint. Although many of the checkpoint proteins that transduce damage signals have been identified and characterized, the mechanism that senses the ...
Lindsay, Howard D.   +3 more
core   +5 more sources

Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0

open access: yes, 2022
Immunotherapy (IT) in the form of monoclonal antibodies targeting coreceptors involved in the modulation of the immune synapse represents a standard of care for patients with distinct malignancies.
Andréia Cristina de Melo   +22 more
core   +1 more source

Immune Checkpoint Inhibitors and Neurotoxicity

open access: yesCurrent Neuropharmacology, 2021
: Immune checkpoint inhibitors (ICIs) have recently been used as a promising treatment for cancer, while their toxicity and immune-related side effects can be seen in any organ, including the nervous system. In contrast to other immune-related adverse events (irAEs), neurological irAEs (nAEs) are rare, with ...
Zhao, Zhiyi   +4 more
openaire   +3 more sources

Cardiotoxicity of Immune Checkpoint Inhibitors [PDF]

open access: yesCurrent Oncology Reports, 2021
Immune checkpoint inhibitors (ICIs) have improved the survival of several cancers. However, they may cause a wide range of immune-related adverse events (irAEs). While most irAEs are manageable with temporary cessation of ICI and immunosuppression, cardiovascular toxicity can be associated with high rates of morbidity and mortality.
Rushin P. Patel   +6 more
openaire   +2 more sources

Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis

open access: yesClinical & Translational Immunology, 2020
Objectives New targets or strategies are needed to increase the success of immune checkpoint‐based immunotherapy for multiple myeloma (MM). However, immune checkpoint signals in MM microenvironment have not been fully elucidated. Here, we aimed to have a
Jinheng Wang   +6 more
doaj   +1 more source

Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation

open access: yesJournal of Hematology & Oncology, 2017
Adaptive immunity is critical for disease progression and modulates T cell (TC) and antigen-presenting cell (APC) functions. Three signals were initially proposed for adaptive immune activation: signal 1 antigen recognition, signal 2 co-stimulation or co-
Jin Dai   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy